Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wienhold (Berlin, Germany), M. Brack (Berlin, Germany), G. Nouailles (Berlin, Germany), C. Seitz (Braunschweig, Germany), A. Ross (Braunschweig, Germany), H. Ziehr (Braunschweig, Germany), K. Dietert (Berlin, Germany), C. Gurtner (Berlin, Germany), O. Kershaw (Berlin, Germany), A. Gruber (Berlin, Germany), M. Rohde (Braunschweig, Germany), N. Suttorp (Berlin, Germany), C. Rohde (Braunschweig, Germany), M. Witzenrath (Berlin, Germany). Therapeutic intratracheal phage application against Acinetobacter baumannii lung infection in mice. 5453

Member's Comments

No comment yet.

Related content which might interest you: Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Newly isolated bacteriophage multidrug-resistant Acinetobacter baumannii inhibition in ex vivo precision cut lung slices Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Highly concentrated aerosolized tobramycin in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Inhaled colistin on Acinetobacter baumannii treatment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated? Source: Eur Respir J 2011; 38: 1483-1486 Year: 2011 Effects of PC945, a novel antifungal agent optimised for lung delivery, on Candida albicans lung infection in mice Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 The resistance rates of Acinetobacter baumannii at endotracheal aspirate cultures Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Pulmonary infections with pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Comparative results of preemptive therapies in mechanically ventilated patients with carbapanem-resistant Acinetobacter baumannii (CRAB) Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment Year: 2017 Tobramycin by aerosol (Toby®) eradicates Pseudomonas aeruginosa resistant to Tobramycin i.v. in patients with infected bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001